{"description":"All-cause mortality: All treated analysis set included all enrolled participants who received at least 1 dose of study drug. Serious and other adverse events: Safety analysis set included all enrolled participants who received at least 1 dose of study drug.","eventGroups":[{"deathsNumAffected":3,"deathsNumAtRisk":17,"description":"Participants with relapsed or refractory waldenstrom's macroglobulinemia received ibrutinib 420 milligrams (mg) (3\\*140 mg capsules) orally once daily from Day 1 of Week 1 until disease progression, unacceptable toxicity, whichever occurs first.","id":"EG000","otherNumAffected":17,"otherNumAtRisk":17,"seriousNumAffected":9,"seriousNumAtRisk":17,"title":"Ibrutinib 420 mg"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":17}],"term":"Anaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Lymphopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Cardiac Failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Palpitations"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Ventricular Arrhythmia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Vertigo"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Retinal Haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Abdominal Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":17}],"term":"Abdominal Pain Upper"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Diarrhoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Gastrointestinal Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Mouth Haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Mouth Ulceration"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Oedema Peripheral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Cholecystitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Anal Abscess"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Bacterial Prostatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Bronchitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Covid-19"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Eye Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Gingivitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Herpes Simplex"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Herpes Zoster"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Orchitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Pharyngitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":17}],"term":"Upper Respiratory Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Urinary Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Fracture"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Head Injury"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Alanine Aminotransferase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Aspartate Aminotransferase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Blood Bilirubin Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Blood Creatinine Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Blood Lactate Dehydrogenase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Blood Urea Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Hepatitis B DNA Assay Positive"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":17}],"term":"Neutrophil Count Decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":17}],"term":"Platelet Count Decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Weight Decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":17}],"term":"Weight Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":17}],"term":"White Blood Cell Count Decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Hypercalcaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Hyperglycaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":17}],"term":"Hyperuricaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":17}],"term":"Hypoalbuminaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Hypocalcaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Hyponatraemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Arthralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Back Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Joint Swelling"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Ovarian Cancer"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Haemorrhage Intracranial"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Hypoaesthesia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Neuralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Peripheral Sensory Neuropathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Haematuria"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Renal Failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Ureterolithiasis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Cough"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Epistaxis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Oropharyngeal Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Pharyngeal Haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Ecchymosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":17}],"term":"Eczema"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Henoch-Schonlein Purpura"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Purpura"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":17}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Hypertension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Scalp Haematoma"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Anal Abscess"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Bacterial Prostatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Covid-19 Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Orchitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Fracture"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Lumbar Vertebral Fracture"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Lung Squamous Cell Carcinoma Stage 0"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Haemorrhage Intracranial"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Peripheral Sensory Neuropathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Ureterolithiasis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":17}],"term":"Pleural Effusion"}],"timeFrame":"All-cause mortality: From Day 1 up to 49.3 months; Serious and other adverse events: From first dose of study drug (Day 1) up to 30 days after last dose of study drug (up to 45.9 months)"}